|
Some years ago, the scientist Edward Fredkin identified a quirk of human behavior. When it comes to making decisions, Fredkin found, we tend to allocate our time inefficiently. Suppose, for example, you’re at the grocery store, looking for something basic like paper towels. In a big supermarket, there might be a dozen or more choices. The result: Because there are so many options, it can be hard to choose among them. In the absence of big differences, Fredkin observed, we tend to get bogged down by the details and spend an inordinate amount of time over-analyzing small differences. In Fredkin’s view, there’s nothing wrong with being a careful consumer. If it takes just a minute to calculate which brand of paper towels is the better deal, there’s nothing wrong with that. The larger concern, in Fredkin’s view, is how consumers approach bigger, more consequential decisions, where the outcome can have a material impact. Because these larger questions are harder to answer—and thus require more mental energy—Fredkin found that people tend to spend less time than they should on them. In many cases, for example, we might procrastinate on a decision because it’s complicated or feels like a black box. That’s Fredkin’s paradox: We tend to spend less time on decisions that can really move the needle and more time on relatively minor questions where the result won’t make much of a difference either way. Fredkin’s paradox presents itself frequently in personal finance. Suppose, for example, you’re selecting investments for your portfolio and trying to decide whether Fidelity’s new zero-fee mutual funds would be a good choice. To help decide, you could compare the performance of these funds to comparable funds from Vanguard, which offers funds that are very low-cost but not entirely free. Here’s what you’d find: Over the past five years, Fidelity’s zero-cost total-market fund (ticker: FZROX) has beaten its closest Vanguard competitor (ticker: VTSAX) by about two percentage points. That would seem to make sense. If two funds are essentially the same, but one carries a fee and the other doesn’t, it stands to reason that the no-fee fund would come out ahead. But that’s just one fund. If you look at another of these no-fee funds, you’ll see precisely the opposite result. Over the past five years, Vanguard’s S&P 500 fund (ticker: VFIAX) has beaten Fidelity’s zero-cost equivalent by a few points. What, then, should an investor conclude about these zero-fee funds? Based on the data, there’s no clear conclusion. And that’s where Fredkin’s paradox kicks in. Without a clear answer, a smart consumer would be inclined to continue researching the question, looking for some difference that might tip the scales. That seems logical. But what Fredkin would tell us is that it simply isn’t worth the effort. Ultimately, the cost difference among all these funds is insignificant, and thus, the results are likely to be almost identical. Informal as it might sound, we should simply choose one and move on. That would free up time to spend on bigger-picture decisions which are likely to make more of a difference. As the end of the year approaches, here are a dozen such questions that may be worth your time:
|